31 May 2022
Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device
Author: admintech | Filed under: Press ReleaseCardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications. CAESAREA, Israel, May 31, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a…